Mitral Stenosis Clinical Trial
Official title:
Left Atrial Appendage (LAA) Clot With Severe Mitral Stenosis, Responders and Non-responders With Anticoagulation
Consecutive patients with severe mitral stenosis and clot in left atrial appendage (LAA) on transesophageal echocardiography fulfilling the inclusion criteria will be recruited for this study. An ACUSON 128-XP echocardiographic system equipped with omniplane and biplane transesophageal probes will be used for this study. TEE followed by CT Angiography will be performed according to the standard procedure after obtaining informed consent.
Consecutive patients with severe mitral stenosis and clot in left atrial appendage (LAA) on transesophageal echocardiography fulfilling the inclusion criteria will be recruited for this study. An ACUSON 128-XP echocardiographic system equipped with omniplane and biplane transesophageal probes will be used for this study. TEE followed by CT Angiography will be performed according to the standard procedure after obtaining informed consent. Demographic profile of the patients will be recorded like gender and age. And baseline TEE will be interpreted and parameters such as mean MVO (cm2), mean MPG (mmHg), and mean LA size (AP diameter, cm) will be recorded. LAA morphologies will be classified as per the operational definition. All the patients will be put on oral anticoagulation with Warfarin. The international normalized ratio (INR) will be maintained between 2.5 and 3.5. Patients will be prescribed with warfarin initial with 5 mg of daily dosage. Weekly INR monitoring will be performed via weekly calls to each and every patients and their INR level will be obtained. Warfarin daily dosage will be adjusted after every month based on target INR range. Repeat TEE will be performed after three (3) months in all the patients. And presence and absence of clot in different types of LAA will be recorded. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06167213 -
ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral
|
N/A | |
Completed |
NCT02188862 -
Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region
|
N/A | |
Recruiting |
NCT04045093 -
Dabigatran for Mitral Stenosis Atrial Fibrillation
|
Phase 4 | |
Recruiting |
NCT05625607 -
Polish Transcatheter Transfemoral Mitral Valve-in-Valve Implantation (Mitral ViV) Registry
|
||
Not yet recruiting |
NCT06067815 -
Assessment of Right Ventricular Function in Patients With Severe Mitral Stenosis Before and After Balloon Mitral Valvuloplasty
|
||
Completed |
NCT01022463 -
Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm
|
Phase 3 | |
Terminated |
NCT03926156 -
RIvoraxaban in Mitral Stenosis
|
Phase 3 | |
Not yet recruiting |
NCT06377449 -
Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients
|
N/A | |
Recruiting |
NCT04408430 -
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
|
N/A | |
Active, not recruiting |
NCT06191718 -
Clinical Investigation for the Foldax Tria Mitral Valve- India
|
N/A | |
Recruiting |
NCT03991910 -
The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients
|
Phase 3 | |
Completed |
NCT02783248 -
French National Observatory of Percutaneous Mitral Commissurotomy
|
||
Recruiting |
NCT05925335 -
The China Mviv Registry
|
N/A | |
Not yet recruiting |
NCT06340997 -
Impact of Percutaneous Transvenous Mitral Commissurotomy on The Left Atrial Appendage Function in Patients With Mitral Stenosis.
|
N/A | |
Completed |
NCT02502448 -
Acute Normovolemic Hemodilution on ROTEM in Cardiac Surgery
|
N/A | |
Completed |
NCT04527367 -
Epidemiology and Long-term Outcome of Patients With VHD
|
||
Active, not recruiting |
NCT05526560 -
Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve
|
||
Completed |
NCT06371222 -
Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm
|
Phase 4 | |
Completed |
NCT02831270 -
Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery
|
N/A | |
Recruiting |
NCT01270750 -
Bosentan for Severe Mitral Valve Dysfunction
|
Phase 1/Phase 2 |